OneSource Specialty Pharma Limited (BOM:544292)

India flag India · Delayed Price · Currency is INR
1,472.35
+20.20 (1.39%)
At close: Mar 30, 2026
Market Cap168.87B +4.0%
Revenue (ttm)14.19B +30.0%
Net Income201.02M
EPS1.75
Shares Outn/a
PE Ratio840.07
Forward PE51.67
Dividendn/a
Ex-Dividend Daten/a
Volume42,510
Average Volume29,638
Open1,410.90
Previous Close1,452.15
Day's Range1,390.00 - 1,488.00
52-Week Range1,075.00 - 2,249.65
Betan/a
RSI56.38
Earnings DateMay 7, 2026

About BOM:544292

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pe... [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Employees 1,412
Stock Exchange Bombay Stock Exchange
Ticker Symbol 544292
Full Company Profile

Financial Performance

In fiscal year 2025, BOM:544292's revenue was 14.45 billion, an increase of 740.43% compared to the previous year's 1.72 billion. Losses were -179.71 million, -95.41% less than in 2024.

Financial Statements